Mylan Laboratories Limited Dexamethasone Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Dexamethasone Export Records India — #6 Exporter, 135 Shipments, $6.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dexamethasone

India Pharmaceutical Trade Intelligence

$181.4M808 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES62.7%India → ETHIOPIA8.0%

ImportsBRAZIL → India$30.7B CHINA → India$42.9M

#1 Buyer: DR REDDYS

Mylan Laboratories Limited — Dexamethasone Exporter #6 | $6.1M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Dexamethasone Exporter Profile

Indian Pharmaceutical Exporter · #6 for Dexamethasone · $6.1M export value · DGFT Verified

Mylan Laboratories Limited is the #6 Indian exporter of Dexamethasone with $6.1M in export value and 135 verified shipments. Mylan Laboratories Limited holds a 3.4% market share in Dexamethasone exports across 4 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Dexamethasone Export Profile: Buyers & Destinations

Mylan Laboratories Limited Dexamethasone export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Dexamethasone?

Country	Value	Shipments	Share
UNITED STATES	$3.2M	66	62.1%
AUSTRALIA	$1.9M	64	36.9%
BURKINA FASO	$43.7K	4	0.8%
PHILIPPINES	$9.2K	1	0.2%

Who Are the Top Buyers of Dexamethasone from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN INSTITUTIONAL INC 2898	UNITED STATES	$1.9M	39
MYLAN AUSTRALIA	AUSTRALIA	$1.8M	53
M/S..MYLAN INSTITUTIONAL INC	UNITED STATES	$620.5K	13
MYLAN INSTITUTIONAL INC.	UNITED STATES	$499.2K	10
MYLAN INSTITUTIONAL INC	UNITED STATES	$150.0K	3
ALPHAPHARM PTY LTD	AUSTRALIA	$102.8K	11
M S MYLAN INSTITUTIONAL INC	UNITED STATES	$49.4K	1
PROGRAMME D APPUI AU DEVELOPPEMENT	BURKINA FASO	$43.7K	4
DEPARTMENT OF HEALTH	PHILIPPINES	$9.2K	1

Mylan Laboratories Limited supplies Dexamethasone to 9 buyers globally. The largest buyer is MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), followed by MYLAN AUSTRALIA (AUSTRALIA) and M/S..MYLAN INSTITUTIONAL INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dexamethasone Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL A	$852.8K	18
DEXAMETHASONE VIATRIS INJ 8MG/2ML-5S-AUS	$250.0K	5
DEXAMETHASONE VIATRIS INJ 8MG/2ML-5S AUS	$150.0K	3
DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 4MG/ML1ML25S MYLAN,US	$148.9K	3
DEXAMETHASONE VIATRIS INJ 8MG/2ML 5S AUS	$100.0K	2
DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 4MG/ML1ML25SMYLAN,USBATCHNO:7610296 TAXABLE VALUE:4432508.68	$100.0K	2
Dexamethasone Sodium Phosphate InjectionUSP [4mg/mL] [30ML] [25`][Mylan,US] Batch No - 3234934	$100.0K	2
DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/ BATCH NO:7608895 TAXABLE VALUE:2272425.33	$51.5K	2
DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/BATCH NO:7608882/ TAXABLE VALUE:2251519.19	$51.0K	2
DEXAMETHASONE VIATRIS INJ 4MG/1ML-5S-AUS/ BATCH NO: 7608896 / TAXABLE VALUE :2242724.19	$50.8K	2

Mylan Laboratories Limited exports 97 distinct Dexamethasone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DEXAMETHASONE MYLAN INJ 8MG/2ML 5S MYL A with 18 shipments worth $852.8K.

How Does Mylan Laboratories Limited Compare to Nearest Dexamethasone Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	MYLAN LABORATORIES LIMITED ★	$6.1M	135	4	$45.1K
7	SENTISS PHARMA PRIVATE LIMITED	$4.5M	90	6	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.3M	65	5	$50.0K

Mylan Laboratories Limited ranks #6 among 808 Indian Dexamethasone exporters. Average shipment value of $45.1K compared to the market average of $39.8K. The closest competitors by value are SENTISS PHARMA PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Dexamethasone Exports?

Port	Shipments	% Share
SAHAR AIR	1,214	13.8%
SAHAR AIR CARGO ACC (INBOM4)	1,121	12.8%
NHAVA SHEVA SEA (INNSA1)	748	8.5%
DELHI AIR CARGO ACC (INDEL4)	509	5.8%
DELHI AIR	476	5.4%
JNPT/ NHAVA SHEVA SEA	472	5.4%
Bombay Air	327	3.7%
JNPT	320	3.6%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Dexamethasone Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 135 individual customs records matching Mylan Laboratories Limited exporting Dexamethasone, covering 97 formulations to 4 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 176+ countries, 2,257+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dexamethasone

Dexamethasone

Mylan Laboratories Limited — Dexamethasone Exporter Profile

Mylan Laboratories Limited — Dexamethasone Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Dexamethasone?

Who Are the Top Buyers of Dexamethasone from Mylan Laboratories Limited?

What Is India's Total Dexamethasone Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Dexamethasone Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Dexamethasone Exporters?

What Dexamethasone Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Dexamethasone to Key Markets

United States — FDA

Australia — TGA

How Does Mylan Laboratories Limited Compare to Nearest Dexamethasone Exporters?

Which Indian Ports Ship Dexamethasone Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Dexamethasone Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dexamethasone Export Data from Mylan Laboratories Limited

Dexamethasone Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source